<DOC>
	<DOCNO>NCT02173392</DOCNO>
	<brief_summary>A healthy subject , 2-way cross-over study evaluate bioequivalence single 1.5mL dose Brodalumab ( 140mg/mL ) vs. two dos ( 1.0mL + 0.5mL ) Brodalumab ( 140mg/mL )</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Single 1.5mL Dose Brodalumab vs. Two Doses ( 1.0mL + 0.5mL ) Brodalumab</brief_title>
	<detailed_description />
	<criteria>healthy male female BMI 18.0 30.0 kg/m2 , inclusive . Females must nonreproductive potential history evidence clinically significant disorder would pose risk subject safety interfere study evaluation , procedure , completion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>